Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool

Blood

Volumn 115, Issue 23, 2010, Pages 4902-4909

  Shahani, Tina ^a   Lavend'homme, Renaud ^a   Luttun, Aernout ^a   Saint Remy, Jean Marie ^a   Peerlinck, Kathelijne ^a   Jacquemin, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR 8; PHORBOL 13 ACETATE 12 MYRISTATE; ADRENERGIC RECEPTOR STIMULATING AGENT; CARCINOGEN; F8 PROTEIN, HUMAN;

AORTA; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART; HUMAN; HUMAN CELL; INTESTINE; LUNG; MICROVASCULATURE; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; PULMONARY ARTERY; SKIN; UMBILICAL ARTERY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; ANTIBODY SPECIFICITY; DRUG EFFECT; PHYSIOLOGY; SECRETION;

ADRENERGIC AGONISTS; CARCINOGENS; ENDOTHELIAL CELLS; EPINEPHRINE; FACTOR VIII; HUMANS; ORGAN SPECIFICITY; STRESS, PHYSIOLOGICAL; TETRADECANOYLPHORBOL ACETATE;

EID: 77954729893     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-232546     Document Type: Article

References (36)

1. Marchioro TL, Hougie C, Ragde H, Epstein RB, Thomas ED. Hemophilia: role of organ homografts. Science. 1969;163(863):188-190.
2. Webster WP, Zukoski CF, Hutchin P, Reddick RL, Mandel SR, Penick GD. Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol. 1971;220(5):1147-1154.
3. Bontempo FA, Lewis JH, Gorenc TJ, et al. Liver transplantation in hemophilia A. Blood. 1987;69(6):1721-1724.
4. Madeira CL, Layman ME, de Vera RE, Fontes PA, Ragni MV. Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver. Blood. 2009;113(21):5364-5365.
5. Rapaport SI, Ames SB, Mikkelsen S, Goodman JR. Plasma clotting factors in chronic hepatocellular disease. N Engl J Med. 1960;263:278-282.
6. Kelly DA, Summerfield JA, Tuddenham EG. Localization of factor VIIIC: antigen in guinea-pig tissues and isolated liver cell fractions. Br J Haematol. 1984;56(4):535-543.
7. Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985;317(6039):726-729. (Pubitemid 16223638)
8. Exner T, Rickard KA, Kronenberg H. Measurement of factor VIII CAg by immunoradiometric assay in human tissue extracts. Thromb Res. 1983;32(4):427-436.
9. Veltkamp JJ, Asfaou E, van de Torren K, van der Does JA, van Tilburg NH, Pauwels EK. Extrahepatic factor VIII synthesis. Lung transplants in hemophilic dogs. Transplantation. 1974;18(1):56-62.
10. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo-a closer look. Thromb Haemost. 2001;86(3):855-861.
11. Doering CB, Parker ET, Nichols CE, Lollar P. Decreased factor VIII levels during acetaminophen-induced murine fulminant hepatic failure. Blood. 2003;102(5):1743-1744.
12. Jacquemin M, Neyrinck A, Hermanns MI, et al. FVIII production by human lung microvascular endothelial cells. Blood. 2006;108(2):515-517. (Pubitemid 44061350)
13. Rizza CR. Effect of exercise on the level of antihaemophilic globulin in human blood. J Physiol. 1961;156:128-135.
14. Cohen RJ, Epstein SE, Cohen LS, Dennis LH. Alterations of fibrinolysis and blood coagulation induced by exercise, and the role of beta-adrenergic- receptor stimulation. Lancet. 1968;2(7581):1264-1266.
15. Corrall RJ, Webber RJ, Frier BM. Increase in coagulation factor VIII activity in man following acute hypoglycaemia: mediation via an adrenergic mechanism. Br J Haematol. 1980;44(2):301-305.
16. Grant PJ. Hormonal regulation of the acute haemostatic response to stress. Blood Coagul Fibrinolysis. 1990;1(3):299-306.
17. Ayoubi TA, Meulemans SM, Roebroek AJ, Van de Ven WJ. Production of recombinant proteins in Chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin. Mol Biol Rep. 1996;23(2):87-95.
18. Jacquemin M, Lavend'homme R, Benhida A, et al. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. Blood. 2000;96(3):958-965.
19. Jacquemin MG, Desqueper BG, Benhida A, et al. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood. 1998;92(2):496-506.
20. Gilles J.G GS, Jaquemin M, Saint-Remy JM. A limited number of anti-idiotypic antibodies is required to maintain FVIII function in presence of polyclonal anti-FVIII antibodies of haemophilia A patients with inhibitors [abstract]. Blood. 2006;108(11):Abstract 299.
21. Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J. von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J. 1997;324(Pt 1):185-191.
22. Plikaytis BD, Holder PF, Pais LB, Maslanka SE, Gheesling LL, Carlone GM. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol. 1994;32(10):2441-2447.
23. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-873. (Pubitemid 33096224)
24. Vischer UM, Wollheim CB. Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis. Thromb Haemost. 1997;77(6):1182-1188.
25. Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays. 1994;16(12):901-906. (Pubitemid 24974469)
26. Rosenberg JB, Greengard JS, Montgomery RR. Genetic induction of a releasable pool of factor VIII in human endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20(12):2689-2695.
27. Ingram GI, Jones RV. The rise in clotting factor 8 induced in man by adrenaline: effect of alpha-and beta-blockers. J Physiol. 1966;187(2):447-454.
28. Ingram GI. Increase in antihaemophilic globulin activity following infusion of adrenaline. J Physiol. 1961;156:217-224.
29. Hoppener MR, Kraaijenhagen RA, Hutten BA, Buller HR, Peters RJ, Levi M. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. J Thromb Haemost. 2004;2(8):1316-1320.
30. Rosenberg JB, Foster PA, Kaufman RJ, et al. Intracellular trafficking of factor VIII to von Willebrand factor storage granules. J Clin Invest. 1998;101(3):613-624.
31. van den Biggelaar M, Meijer AB, Voorberg J, Mertens K. Intracellular cotrafficking of factor VIII and von Willebrand factor type 2N variants to storage organelles. Blood. 2009;113(13):3102-3109.
32. van den Biggelaar M, Bierings R, Storm G, Voorberg J, Mertens K. Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost. 2007;5(11):2235-2242.
33. Montgomery RR, Gill JC. Interactions between von Willebrand factor and factor VIII: where did they first meet. J Pediatr Hematol Oncol. 2000;22(3):269-275.
34. Haberichter SL, Shi Q, Montgomery RR. Regulated release of VWF and FVIII and the biologic implications. Pediatr Blood Cancer. 2006;46(5):547-553.
35. Vischer UM, Barth H, Wollheim CB. Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20(3):883-891.
36. Libre EP, Cowan DH, Watkins SP Jr, Shulman NR. Relationships between spleen, platelets and factor 8 levels. Blood. 1968;31(3):358-368.